Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

B cells are involved in the pathogenesis of chronic GVHD (cGVHD). We hypothesized that prophylactic anti–B-cell therapy delivered 2 months after transplantation would decrease allogeneic donor B-cell immunity and possibly the incidence of cGVHD. Therefore, in the present study, patients with high-ri...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Arai, Sally, Sahaf, Bita, Narasimhan, Balasubramanian, Chen, George L., Jones, Carol D., Lowsky, Robert, Shizuru, Judith A., Johnston, Laura J., Laport, Ginna G., Weng, Wen-Kai, Benjamin, Jonathan E., Schaenman, Joanna, Brown, Janice, Ramirez, Jessica, Zehnder, James L., Negrin, Robert S., Miklos, David B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2012
Teme:
Clinical Trials and Observations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383022/
https://ncbi.nlm.nih.gov/pubmed/22563089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-12-395970
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items